2008 U.S. Diabetes Drug Delivery - Patient Perspective

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about awareness, usage, and desired changes was obtained for Exubera and Byetta. For device driven delivery, autoinjector technology usage and willingness for adoption is assessed by patients, as well as other vital feedback on the role the device plays in the overall drug product. The corresponding physician deliverable is titled: 2008 U.S. Diabetes Drug Delivery - Physician Perspective (N7A6).

Table of Contents

2008 U.S. Diabetes Drug Delivery - Patient Perspective, 2008 U.S. Diabetes Drug Delivery - Patient PerspectiveIntroductionTitleDisclaimerCertificationTable of ContentsResearch Background - Objectives - Method Details - Demographic ProfileResearch BackgroundMethod DetailsScopeDemographic Profile of RespondentsExecutive SummaryExecutive SummaryOverview of Awareness - Usage - PreferencesMedication Taken for the Past 6 Months or LongerGeneral Awareness of Drug Delivery TypesOverview of Drug Delivery PreferencesDiabetes Type IDrug Delivery Method – Availability & Usage: Diabetes Type IFrequency of Usage of Drug Delivery Method: Diabetes Type IDrug Delivery Method – Satisfaction with Method Used: Diabetes Type IInjection Delivery Device – Diabetes Type IDrug Delivery Method – Willingness to Use: Diabetes Type IReasons for Willingness to Use Drug Delivery Methods: Diabetes Type IBarriers for Usage of Drug Delivery Methods – Diabetes Type IReasons for Preference of Drug Delivery Methods – Diabetes Type IDiabetes Type IIDrug Delivery Method – Availability & Usage: Diabetes Type IIFrequency of Usage of Drug Delivery Method: Diabetes Type IIDrug Delivery Method – Satisfaction with Method Used: Diabetes Type IIInjection Delivery Device – Diabetes Type IIDrug Delivery Method – Willingness to Use: Diabetes Type IIReasons for Willingness to Use Drug Delivery Methods: Diabetes Type IIBarriers for Usage of Drug Delivery Methods – Diabetes Type IIReasons for Preference of Drug Delivery Methods – Diabetes Type IIGeneral Criteria and Perceptions that Influence Drug Delivery Type PreferenceFactors for Selecting Drug Delivery Type among Diabetes Type I PatientsFactors for Selecting Drug Delivery Type among Diabetes Type II PatientsKey Source of Discomfort for Drug Delivery Methods Patients are Unwilling to Use Due to High DiscomfortPerceived Association of Delivery Types with Various AttributesPerson Administering Drug Among Diabetes Type I PatientsPerson Administering Drug Among Diabetes Type II PatientsDrug Regimen – Desirability: Diabetes Type IDrug Regimen – Desirability: Diabetes Type IIDevice Driven Drug Delivery Method Among Diabetes Type I Patients – FactorsDevice Driven Drug Delivery Method Among Diabetes Type II Patients – FactorsWillingness to Try New Drug Delivery Method Based on Cost and Tolerance for Side EffectsWillingness to Try New Drug Delivery Method Based on Price PremiumProfile of Diabetes Type I Patients’ Attitudes and Perceptions - An OverviewProfile of Diabetes Type II Patients’ Attitudes and Perceptions - An OverviewProfile of Patients’ Attitudes and PerceptionsAutoinjector: Usage and Future AdoptionPotential Impact of Autoinjector on Injection Delivery Willingness to UseDegree of Willingness to Use Autoinjector in the FutureProfile of Selected Brands: Awareness - Usage - Satisfaction - Desired ImprovementsExubera - AwarenessExubera - Usage - Satisfaction - Desired Improvements Among Diabetes PatientsByetta - AwarenessByetta - Usage - Satisfaction - Desired Improvements Among Diabetes PatientsAbout Frost & SullivanFrost & Sullivan




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.